VIM and benign prostatic hyperplasia: We further indicated Y-27632 down-regulated fibrosis markers (Collagen I and α-SMA) dose-dependently in WPMY-1, while inhibited EMT process with Vimentin and N-Cad decreased, along with E-Cad increased in BPH-1 (Fig. 3c).